{"database": "lobbying", "table": "lobbying_activities", "is_view": false, "human_description_en": "where filing_uuid = \"d6b8d5b9-9d3f-4e10-9d00-3a2d07b60e80\" sorted by filing_year descending", "rows": [[3329253, "d6b8d5b9-9d3f-4e10-9d00-3a2d07b60e80", "Q1", "GOVERNMENT SOLUTIONS LLC", 401103251, "OTSUKA AMERICA PHARMACEUTICAL, INC.", 2025, "first_quarter", "VET", "Veterans Affairs, Mental Health, and Posttraumatic stress disorder (PTSD). Specifically, health care policies relating to mental health and PTSD. Veterans Affairs authorizations and appropriations issues related to mental health and PTSD.", "HOUSE OF REPRESENTATIVES,SENATE", 30000, null, 0, 0, "2025-04-06T18:03:19-04:00"], [3329254, "d6b8d5b9-9d3f-4e10-9d00-3a2d07b60e80", "Q1", "GOVERNMENT SOLUTIONS LLC", 401103251, "OTSUKA AMERICA PHARMACEUTICAL, INC.", 2025, "first_quarter", "HCR", "Mental Health, Brain Health, and Posttraumatic stress disorder (PTSD). Specifically, health care policies relating to mental health and PTSD. Federal authorizations and appropriations issues related to mental health and PTSD.", "HOUSE OF REPRESENTATIVES,SENATE", 30000, null, 0, 0, "2025-04-06T18:03:19-04:00"], [3329255, "d6b8d5b9-9d3f-4e10-9d00-3a2d07b60e80", "Q1", "GOVERNMENT SOLUTIONS LLC", 401103251, "OTSUKA AMERICA PHARMACEUTICAL, INC.", 2025, "first_quarter", "DEF", "Military Health Care, Mental Health, and Posttraumatic stress disorder (PTSD). Specifically, health care policies relating to mental health and PTSD. Defense authorizations and appropriations issues related to mental health and PTSD.", "HOUSE OF REPRESENTATIVES,SENATE", 30000, null, 0, 0, "2025-04-06T18:03:19-04:00"], [3530115, "d6b8d5b9-9d3f-4e10-9d00-3a2d07b60e80", "Q1", "GOVERNMENT SOLUTIONS LLC", 401103251, "OTSUKA AMERICA PHARMACEUTICAL, INC.", 2025, "first_quarter", "VET", "Veterans Affairs, Mental Health, and Posttraumatic stress disorder (PTSD). Specifically, health care policies relating to mental health and PTSD. Veterans Affairs authorizations and appropriations issues related to mental health and PTSD.", "HOUSE OF REPRESENTATIVES,SENATE", 30000, null, 0, 0, "2025-04-06T18:03:19-04:00"], [3530116, "d6b8d5b9-9d3f-4e10-9d00-3a2d07b60e80", "Q1", "GOVERNMENT SOLUTIONS LLC", 401103251, "OTSUKA AMERICA PHARMACEUTICAL, INC.", 2025, "first_quarter", "HCR", "Mental Health, Brain Health, and Posttraumatic stress disorder (PTSD). Specifically, health care policies relating to mental health and PTSD. Federal authorizations and appropriations issues related to mental health and PTSD.", "HOUSE OF REPRESENTATIVES,SENATE", 30000, null, 0, 0, "2025-04-06T18:03:19-04:00"], [3530117, "d6b8d5b9-9d3f-4e10-9d00-3a2d07b60e80", "Q1", "GOVERNMENT SOLUTIONS LLC", 401103251, "OTSUKA AMERICA PHARMACEUTICAL, INC.", 2025, "first_quarter", "DEF", "Military Health Care, Mental Health, and Posttraumatic stress disorder (PTSD). Specifically, health care policies relating to mental health and PTSD. Defense authorizations and appropriations issues related to mental health and PTSD.", "HOUSE OF REPRESENTATIVES,SENATE", 30000, null, 0, 0, "2025-04-06T18:03:19-04:00"], [3601320, "d6b8d5b9-9d3f-4e10-9d00-3a2d07b60e80", "Q1", "GOVERNMENT SOLUTIONS LLC", 401103251, "OTSUKA AMERICA PHARMACEUTICAL, INC.", 2025, "first_quarter", "VET", "Veterans Affairs, Mental Health, and Posttraumatic stress disorder (PTSD). Specifically, health care policies relating to mental health and PTSD. Veterans Affairs authorizations and appropriations issues related to mental health and PTSD.", "HOUSE OF REPRESENTATIVES,SENATE", 30000, null, 0, 0, "2025-04-06T18:03:19-04:00"], [3601321, "d6b8d5b9-9d3f-4e10-9d00-3a2d07b60e80", "Q1", "GOVERNMENT SOLUTIONS LLC", 401103251, "OTSUKA AMERICA PHARMACEUTICAL, INC.", 2025, "first_quarter", "HCR", "Mental Health, Brain Health, and Posttraumatic stress disorder (PTSD). Specifically, health care policies relating to mental health and PTSD. Federal authorizations and appropriations issues related to mental health and PTSD.", "HOUSE OF REPRESENTATIVES,SENATE", 30000, null, 0, 0, "2025-04-06T18:03:19-04:00"], [3601322, "d6b8d5b9-9d3f-4e10-9d00-3a2d07b60e80", "Q1", "GOVERNMENT SOLUTIONS LLC", 401103251, "OTSUKA AMERICA PHARMACEUTICAL, INC.", 2025, "first_quarter", "DEF", "Military Health Care, Mental Health, and Posttraumatic stress disorder (PTSD). Specifically, health care policies relating to mental health and PTSD. Defense authorizations and appropriations issues related to mental health and PTSD.", "HOUSE OF REPRESENTATIVES,SENATE", 30000, null, 0, 0, "2025-04-06T18:03:19-04:00"]], "truncated": false, "filtered_table_rows_count": 9, "expanded_columns": [], "expandable_columns": [[{"column": "filing_uuid", "other_table": "lobbying_filings_raw", "other_column": "filing_uuid"}, "registrant_name"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "units": {}, "query": {"sql": "select id, filing_uuid, filing_type, registrant_name, registrant_id, client_name, filing_year, filing_period, issue_code, specific_issues, government_entities, income_amount, expense_amount, is_no_activity, is_termination, received_date from lobbying_activities where \"filing_uuid\" = :p0 order by filing_year desc limit 101", "params": {"p0": "d6b8d5b9-9d3f-4e10-9d00-3a2d07b60e80"}}, "facet_results": {"issue_code": {"name": "issue_code", "type": "column", "hideable": false, "toggle_url": "/lobbying/lobbying_activities.json?filing_uuid=d6b8d5b9-9d3f-4e10-9d00-3a2d07b60e80", "results": [{"value": "DEF", "label": "DEF", "count": 3, "toggle_url": "https://www.pawtectors.org/lobbying/lobbying_activities.json?filing_uuid=d6b8d5b9-9d3f-4e10-9d00-3a2d07b60e80&issue_code=DEF", "selected": false}, {"value": "HCR", "label": "HCR", "count": 3, "toggle_url": "https://www.pawtectors.org/lobbying/lobbying_activities.json?filing_uuid=d6b8d5b9-9d3f-4e10-9d00-3a2d07b60e80&issue_code=HCR", "selected": false}, {"value": "VET", "label": "VET", "count": 3, "toggle_url": "https://www.pawtectors.org/lobbying/lobbying_activities.json?filing_uuid=d6b8d5b9-9d3f-4e10-9d00-3a2d07b60e80&issue_code=VET", "selected": false}], "truncated": false}, "filing_year": {"name": "filing_year", "type": "column", "hideable": false, "toggle_url": "/lobbying/lobbying_activities.json?filing_uuid=d6b8d5b9-9d3f-4e10-9d00-3a2d07b60e80", "results": [{"value": 2025, "label": 2025, "count": 9, "toggle_url": "https://www.pawtectors.org/lobbying/lobbying_activities.json?filing_uuid=d6b8d5b9-9d3f-4e10-9d00-3a2d07b60e80&filing_year=2025", "selected": false}], "truncated": false}, "filing_period": {"name": "filing_period", "type": "column", "hideable": false, "toggle_url": "/lobbying/lobbying_activities.json?filing_uuid=d6b8d5b9-9d3f-4e10-9d00-3a2d07b60e80", "results": [{"value": "first_quarter", "label": "first_quarter", "count": 9, "toggle_url": "https://www.pawtectors.org/lobbying/lobbying_activities.json?filing_uuid=d6b8d5b9-9d3f-4e10-9d00-3a2d07b60e80&filing_period=first_quarter", "selected": false}], "truncated": false}}, "suggested_facets": [{"name": "specific_issues", "toggle_url": "https://www.pawtectors.org/lobbying/lobbying_activities.json?filing_uuid=d6b8d5b9-9d3f-4e10-9d00-3a2d07b60e80&_facet=specific_issues"}, {"name": "received_date", "type": "date", "toggle_url": "https://www.pawtectors.org/lobbying/lobbying_activities.json?filing_uuid=d6b8d5b9-9d3f-4e10-9d00-3a2d07b60e80&_facet_date=received_date"}], "next": null, "next_url": null, "private": false, "allow_execute_sql": true, "query_ms": 588.0239461548626, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}